Evolus Statistics
Total Valuation
Evolus has a market cap or net worth of $589.31 million. The enterprise value is $651.61 million.
Important Dates
The next estimated earnings date is Wednesday, July 30, 2025, after market close.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Evolus has 64.48 million shares outstanding. The number of shares has increased by 9.99% in one year.
| Current Share Class | 64.48M |
| Shares Outstanding | 64.48M |
| Shares Change (YoY) | +9.99% |
| Shares Change (QoQ) | +0.52% |
| Owned by Insiders (%) | 2.10% |
| Owned by Institutions (%) | 72.83% |
| Float | 54.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.14 |
| Forward PS | 1.52 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.34
| Current Ratio | 2.34 |
| Quick Ratio | 2.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.78 |
Financial Efficiency
Return on equity (ROE) is -949.46% and return on invested capital (ROIC) is -15.31%.
| Return on Equity (ROE) | -949.46% |
| Return on Assets (ROA) | -9.36% |
| Return on Invested Capital (ROIC) | -15.31% |
| Return on Capital Employed (ROCE) | -20.95% |
| Revenue Per Employee | $829,708 |
| Profits Per Employee | -$169,286 |
| Employee Count | 332 |
| Asset Turnover | 1.25 |
| Inventory Turnover | 8.07 |
Taxes
In the past 12 months, Evolus has paid $689,000 in taxes.
| Income Tax | 689,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.90% in the last 52 weeks. The beta is 1.00, so Evolus's price volatility has been similar to the market average.
| Beta (5Y) | 1.00 |
| 52-Week Price Change | -14.90% |
| 50-Day Moving Average | 10.19 |
| 200-Day Moving Average | 12.77 |
| Relative Strength Index (RSI) | 40.74 |
| Average Volume (20 Days) | 1,085,511 |
Short Selling Information
The latest short interest is 10.61 million, so 16.45% of the outstanding shares have been sold short.
| Short Interest | 10.61M |
| Short Previous Month | 9.67M |
| Short % of Shares Out | 16.45% |
| Short % of Float | 19.53% |
| Short Ratio (days to cover) | 9.29 |
Income Statement
In the last 12 months, Evolus had revenue of $275.46 million and -$56.20 million in losses. Loss per share was -$0.89.
| Revenue | 275.46M |
| Gross Profit | 188.46M |
| Operating Income | -32.91M |
| Pretax Income | -52.99M |
| Net Income | -56.20M |
| EBITDA | -27.46M |
| EBIT | -32.91M |
| Loss Per Share | -$0.89 |
Full Income StatementBalance Sheet
The company has $67.89 million in cash and $130.20 million in debt, giving a net cash position of -$62.31 million or -$0.97 per share.
| Cash & Cash Equivalents | 67.89M |
| Total Debt | 130.20M |
| Net Cash | -62.31M |
| Net Cash Per Share | -$0.97 |
| Equity (Book Value) | -6.60M |
| Book Value Per Share | -0.10 |
| Working Capital | 75.49M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$23.02 million and capital expenditures -$1.54 million, giving a free cash flow of -$24.55 million.
| Operating Cash Flow | -23.02M |
| Capital Expenditures | -1.54M |
| Free Cash Flow | -24.55M |
| FCF Per Share | -$0.38 |
Full Cash Flow StatementMargins
Gross margin is 68.41%, with operating and profit margins of -11.95% and -20.40%.
| Gross Margin | 68.41% |
| Operating Margin | -11.95% |
| Pretax Margin | -20.15% |
| Profit Margin | -20.40% |
| EBITDA Margin | -9.97% |
| EBIT Margin | -11.95% |
| FCF Margin | n/a |
Dividends & Yields
Evolus does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.99% |
| Shareholder Yield | -9.99% |
| Earnings Yield | -9.54% |
| FCF Yield | -4.17% |
Analyst Forecast
The average price target for Evolus is $23.75, which is 159.85% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $23.75 |
| Price Target Difference | 159.85% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 25.77% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Evolus has an Altman Z-Score of -0.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.62 |
| Piotroski F-Score | 3 |